Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the Hematology Analyzers and Reagents Market Growth Performance Trended Historically, And What Lies Ahead?
In previous years, the market size for hematology analyzers and reagents has experienced considerable growth. A boost from $4.9 billion in 2024 to $5.25 billion in 2025, embodying a compound annual growth rate (CAGR) of 7.1%, is expected. Factors leading to the expansion during the historic period include the surge in chronic diseases, aging demographics, heightened disease burden, and growth in infectious diseases.
What Is the Forecast for the Hematology Analyzers and Reagents Market Size Through 2029?
In the coming years, the hematology analyzers and reagents market is predicted to see a significant increase in growth, reaching $6.63 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%. Factors contributing to this estimated growth during the forecast period include global health issues, increased investments in hematology analyzer and reagent infrastructure, personalized medicine, and remote monitoring expansion. Some of the key trends expected during this period are technology advancements, high-sensitivity testing, molecular hematology testing, automation and integration, point-of-care testing (POCT), data analytics, artificial intelligence and digital hematology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2572&type=smp
What are the Key Market Players in Hematology Analyzers and Reagents Market and How They’re Evolving?
Major companies operating in the hematology analyzers and reagents market include Abbott Laboratories, Bio-Rad Laboratories, Horiba Ltd., Siemens AG, Sysmex Corporation, BioSystems Diagnostics Pvt. Ltd, Boule Diagnostics, Danaher Corporation, Diatron MI PLC, Drew Scientific, EKF Diagnostics, Mindray, Nihon Kohden, Ortho Clinical Diagnostics, Roche, Beckman Coulter, Bayer AG, Heska, Drucker, Instrumentation Laboratory, Abaxis Inc., Accriva Diagnostics, ACON, Diamond Diagnostics, ERBA Diagnostics, Hycel, Maccura Biotechnology Co. Ltd., Genrui Biotech Inc., A&T Corporation, Beijing Succeeder Technology Inc., Diagnostica Stago SAS
What Are the Primary Growth Drivers in the Hematology Analyzers and Reagents Market?
Surges in infectious disease cases are anticipated to fuel the expansion of the hematology analyzers and reagents market. These diseases are caused by harmful microorganisms such as fungi, bacteria, parasites, or viruses and can potentially be transmitted from one person to another or from environmental source. The escalation in infectious diseases can be linked to various interconnected factors like globalization that accelerates the dissemination of pathogens, resistance to antimicrobial drugs due to their excessive use, and certain social and economic conditions. The information derived from hematology analyzers supports epidemiological research as it allows health officials to monitor disease outbreaks and understand the mechanism of disease spread. For example, the Centers for Disease Control and Prevention, a government agency in the US, reported in March 2024 that the number of tuberculosis cases ascended from 8,320 in 2022 to 9,615 in 2023, indicating a surge of 1,295 cases. Consequently, the increasing occurrence of infectious diseases is driving the growth of the hematology analyzer and reagent market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=2572&type=smp
What Are the Leading Segments in the Global Hematology Analyzers and Reagents Industry?
The hematology analyzers and reagents market covered in this report is segmented –
1) By Product: Hematology Analyzers, Hemostasis Analyzers, Plasma Protein Analyzers, Hemoglobin Analyzers, Erythrocyte Sedimentation Rate Analyzer, Coagulation Analyzer, Flow Cytometers, Slide Stainers, Differential Counters, Hematology Stains
2) By Applications: Anemias, Blood Cancers, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, Other Applications
3) By End User: Specialized Research Institutes, Hospitals, Specialized Diagnostic Centers, Other End Users
Subsegments:
1) By Hematology Analyzers: Automated Hematology Analyzers, Semi-Automated Hematology Analyzers
2) By Hemostasis Analyzers: Platelet Function Analyzers, Coagulation Testing Analyzers
3) By Plasma Protein Analyzers: Electrophoresis Analyzers, Immunofixation Analyzers
4) By Hemoglobin Analyzers: Point-Of-Care Hemoglobin Analyzers, Laboratory Hemoglobin Analyzers
5) By Erythrocyte Sedimentation Rate Analyzer: Manual ESR Analyzers, Automated ESR Analyzers
6) By Coagulation Analyzer: Clotting Time Analyzers, Thromboelastography (TEG) Analyzers
What Are the Key Market Trends in the Hematology Analyzers and Reagents Industry?
The market for hematology analyzers and reagents is being restrained due to recalls of faulty devices. These product recalls, implemented by product developers or manufacturers due to safety concerns or defects, can risk the safety of consumers. Inaccurate results from a defective hematology analyzer might lead to misdiagnosis, thereby shaking public trust in these analyzing systems. Regulatory bodies urge healthcare experts to be conscious of the likelihood of error-prone diagnostic outcomes from these devices, and to take suitable measures like using alternative testing procedures or confirming the analyzer results through manual scanning or cell count estimation. For instance, Beckman Coulter Life Sciences had to recall its DxH800, DxH600, and DxH900 hematology analyzers due to the threat of inaccurate outcomes. These product recalls present both a serious safety threat to the public and can inflict considerable financial and reputation harm to the companies involved.
Access The Full Report Here:
What Is the Regional Outlook for the Hematology Analyzers and Reagents Market?
The countries covered in the hematology analyzers and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2572
This Report Delivers Insight On:
1. How big is the hematology analyzers and reagents market, and how is it changing globally?
2. Who are the major companies in the hematology analyzers and reagents market, and how are they performing?
3. What are the key opportunities and risks in the hematology analyzers and reagents market right now?
4. Which products or customer segments are growing the most in the hematology analyzers and reagents market?
5. What factors are helping or slowing down the growth of the hematology analyzers and reagents market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
